A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
Ronald S. Black(Pfizer (United States)), Michael Grundman(University of San Diego), Reisa A. Sperling(Brigham and Women's Hospital), Allan Pallay(Statistical Research (United States)), Beth Safirstein(Velocity Clinical Research (United States)), Ruth Motter, Alice I. Nichols
Cited by 168
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k